ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
India's Union health ministry issued an advisory against unregulated stem cell therapies, restricting their use for autism to approved clinical trials. The move aligns with a Supreme Court ruling and mandates strict compliance from states and clinical establishments.
Tap to vote and see what everyone thinks.
Summary by ByteBrief